Bionomics Shareholders should carefully read the Scheme Booklet in its entirety before deciding on how to vote on the Scheme. The Scheme Meeting will be held at 8:30 am Sydney time on Thursday 12 ...

We think UCB is in good financial health, with solid earnings and cash flow generation. UCB has deleveraged over the years, and it ended 2023 with about EUR 2.2 billion in net debt on its balance ...

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of Alzheimer's disease, ...

The complexity of the central nervous system (CNS) and its pathologies necessitates an intricate understanding of the cellular and molecular mechanisms at play. Single-cell biology has emerged as a ...

The autonomic nervous system orchestrates the functions of internal organs such as the heart and gut, serving as a connection ...

Acadia Pharmaceuticals ACAD announced that it has signed an exclusive worldwide license agreement with Saniona, a Denmark-based clinical-stage biopharmaceutical company, to develop and commercialize ...

"Licensing SAN711 to expand our pipeline underscores our unwavering commitment to delivering innovative therapies for ...

Interoception research reveals how gut-brain communication via neural, hormonal, and microbial pathways regulates metabolism, ...

An international team of researchers has discovered a new component of the peripheral nervous system that acts by increasing energy metabolism in the body.

Researchers have developed a breakthrough system to deliver large therapeutic molecules into the brain, overcoming the challenges of the blood-brain barrier.